UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032643
Receipt number R000037223
Scientific Title Multicenter Prospective Observational Study for the Evaluation of Online or Tele-medicine of Lifestyle Diseases
Date of disclosure of the study information 2018/05/19
Last modified on 2019/11/03 23:50:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Prospective Observational Study for the Evaluation of Online or Tele-medicine of Lifestyle Diseases

Acronym

Multicenter Prospective Online Medicine Registry

Scientific Title

Multicenter Prospective Observational Study for the Evaluation of Online or Tele-medicine of Lifestyle Diseases

Scientific Title:Acronym

Multicenter Prospective Online Medicine Registry

Region

Japan


Condition

Condition

Lifestyle Diseases

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Geriatrics Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of online and tele-medicine for the treatment of lifestyle diseases

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Control status of underlying diseases after implementation of online or telemedicine (maximum of 1-year follow-up)

Key secondary outcomes

Incidence of adverse event after implementation of online or telemedicine (maximum of 1-year follow-up)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Meet both following criteria

1. Patients with lifestyle diseases with whom attending physician think that he/she can provide online or telemedicine using national health-insurance system in Japan.

2. Patients who can understand the study, and can voluntarily get written informed consent.

Key exclusion criteria

Meet one of following criteria

1. Severe cardiac, liver, or renal diseases
2. Malignancy under treatment
3. Participants of other clinical studies within 3 months
4. Patients who can not understand the study such as due to psychiatric disorder
5. Other inappropriate patients based on attending physician's discrestion

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiko Hara, MD, PhD

Organization

Japan Society of Clinical Research

Division name

Department of Clinical Investigation

Zip code


Address

Kita-ku Umeda 1-11-1000 Osaka Ekimae 4th Bldg 10F Osaka, 530-0001 Japan

TEL

06-6131-5495

Email

hara@japanscr.org


Public contact

Name of contact person

1st name
Middle name
Last name Masahiko Hara, MD, PhD

Organization

Japan Society of Clinical Research

Division name

Department of Clinical Investigation

Zip code


Address

Kita-ku Umeda 1-11-1000 Osaka Ekimae 4th Bldg 10F Osaka, 530-0001 Japan

TEL

06-6131-5495

Homepage URL

https://www.japanscr.org

Email

hara@japanscr.org


Sponsor or person

Institute

Japan Society of Clinical Research

Institute

Department

Personal name



Funding Source

Organization

MITSUI & CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 20 Day

Date of IRB

2017 Year 05 Month 17 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2019 Year 11 Month 05 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter Prospective Observational Study of 3 Institutions


Management information

Registered date

2018 Year 05 Month 19 Day

Last modified on

2019 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037223


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name